IP Library Granted Patent US 12,018,065
Granted Patent B2
US 12,018,065 · App. 17/242,170 · Granted Jun 25, 2024

Variant nucleic acid libraries for coronavirus

Inventors: Aaron Sato (Burlingame, CA); Qiang Liu (Palo Alto, CA); Tom Yuan (San Francisco, CA)
Assignee: Twist Bioscience Corporation
C07K16/10C07K16/005A61K2039/505C07K2317/565C07K2317/76C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,018,065
App. No.
17/242,170
Granted
Jun 25, 2024
Kind
B2
Abstract

Provided herein are methods and compositions relating to libraries of optimized antibodies having nucleic acids encoding for an antibody comprising modified sequences. Libraries described herein comprise nucleic acids encoding SARS-CoV-2 or ACE2 antibodies. Further described herein are protein libraries generated when the nucleic acid libraries are translated. Further described herein are cell libraries expressing variegated nucleic acid libraries described herein.

Claims (4)

1. A VHH antibody that binds to ACE2 protein, comprising a variable domain, heavy chain region (VH) wherein VH comprises complementarity determining regions CDRH1, CDRH2, and CDRH3, wherein (a) an amino acid sequence of CDRH1 is as set forth in SEQ ID NO: 39; (b) an amino acid sequence of CDRH2 is as set forth in SEQ ID NO: 89; and (c) an amino acid sequence of CDRH3 is as set forth in SEQ ID NO: 139.

2. A VHH antibody that binds to ACE2 protein, comprising a variable domain, heavy chain region (VH) wherein VH comprises complementarity determining regions CDRH1, CDRH2, and CDRH3, wherein (a) an amino acid sequence of CDRH1 is as set forth in SEQ ID NO: 785; (b) an amino acid sequence of CDRH2 is as set forth in SEQ ID NO: 926; and (c) an amino acid sequence of CDRH3 is as set forth in SEQ ID NO: 1068.

3. A VHH antibody that binds to ACE2 protein, comprising a variable domain, heavy chain region (VH) wherein VH comprises complementarity determining regions CDRH1, CDRH2, and CDRH3, wherein (a) an amino acid sequence of CDRH1 is as set forth in SEQ ID NO: 17; (b) an amino acid sequence of CDRH2 is as set forth in SEQ ID NO: 67; and (c) an amino acid sequence of CDRH3 is as set forth in SEQ ID NO: 117.

4. A VHH antibody that binds to ACE2 protein, comprising a variable domain, heavy chain region (VH) wherein VH comprises complementarity determining regions CDRH1, CDRH2, and CDRH3, wherein (a) an amino acid sequence of CDRH1 is as set forth in SEQ ID NO: 832; (b) an amino acid sequence of CDRH2 is as set forth in SEQ ID NO: 973; and (c) an amino acid sequence of CDRH3 is as set forth in SEQ ID NO: 1115.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2026
From: SATO, AARON; LIU, QIANG; YUAN, TOM
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 075506/0762 →
Continuity (7)
Provisional Application 63115568 · Nov 18, 2020
Provisional Application 63104465 · Oct 22, 2020
Provisional Application 63073362 · Sep 1, 2020
Provisional Application 63069665 · Aug 24, 2020
Provisional Application 63034896 · Jun 4, 2020
Provisional Application 63016254 · Apr 27, 2020
Related Publication 20210355194A1 · Nov 18, 2021